Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
- Fragrance and preservatives to keep the formula stable
TRIUMPH-1 Phase 3 Trial Results (May 2026) On May 21, 2026, Eli Lilly announced topline results from TRIUMPH-1, the pivotal Phase 3 obesity trial for retatrutide
Metabolomic profiling reveals Retatrutide reduces pathways associated with insulin resistance, including sphingolipid metabolism and dicarboxylate metabolismbiomarkers strongly linked to type 2 diabetes pathogenesis
When you start two that have overlapping side effect profiles, that adjustment period can be more pronounced
US$ 20.95
US$ 24.87
US$ 21.60
US$ 20.31
US$ 27.04
US$ 26.17
US$ 28.31
